Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DM3F1L
|
|||
| Drug Name |
Progerinin
|
|||
| Indication | Hutchinson-Gilford progeria syndrome [ICD-11: LD2B] | Phase 2 | [1] | |
| Company |
PRG S&T
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05847179) A Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin for the Treatment of Bone Mineral Density (BMD) Loss in Subjects With Typical Werner Syndrome. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.